Literature DB >> 31620230

3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT2B, 5-HT7, or σ1 Receptor Ligands.

Matthew R Porter1, Haiyan Xiao2,3, Jing Wang2,3, Sylvia B Smith2,3,4, Joseph J Topczewski1.   

Abstract

The phenethylamine backbone is a privileged substructure found in a wide variety of G protein-coupled receptor (GPCR) ligands. This includes both endogenous neurotransmitters and active pharmaceutical agents. More than 20 structurally unique heterocyclic phenethylamine derivatives were broadly evaluated for GPCR affinity. Selective ligands for the 5-HT2B, 5-HT7, and σ1 receptors were identified, each with low nanomolar binding affinities. The σ1 receptor affinity was supported in a cellular assay that provided evidence for increased cell survival under oxidative stress.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31620230      PMCID: PMC6792158          DOI: 10.1021/acsmedchemlett.9b00225

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  38 in total

Review 1.  Pharmacology and physiology of human adrenergic receptor polymorphisms.

Authors:  Kersten M Small; Dennis W McGraw; Stephen B Liggett
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

2.  Drugs and valvular heart disease.

Authors:  Bryan L Roth
Journal:  N Engl J Med       Date:  2007-01-04       Impact factor: 91.245

3.  Stereoselective Dynamic Cyclization of Allylic Azides: Synthesis of Tetralins, Chromanes, and Tetrahydroquinolines.

Authors:  Matthew R Porter; Rami M Shaker; Cristian Calcanas; Joseph J Topczewski
Journal:  J Am Chem Soc       Date:  2018-01-10       Impact factor: 15.419

4.  Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update.

Authors:  Maria N Modica; Enza Lacivita; Sebastiano Intagliata; Loredana Salerno; Giuseppe Romeo; Valeria Pittalà; Marcello Leopoldo
Journal:  J Med Chem       Date:  2018-06-05       Impact factor: 7.446

5.  Sequential cytoprotective responses to Sigma1 ligand-induced endoplasmic reticulum stress.

Authors:  Joel M Schrock; Christina M Spino; Charles G Longen; Stacy M Stabler; Jacqueline C Marino; Gavril W Pasternak; Felix J Kim
Journal:  Mol Pharmacol       Date:  2013-09-04       Impact factor: 4.436

6.  Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.

Authors:  Felix J Kim; Ivanka Kovalyshyn; Maxim Burgman; Claire Neilan; Chih-Cheng Chien; Gavril W Pasternak
Journal:  Mol Pharmacol       Date:  2010-01-20       Impact factor: 4.436

7.  Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1.

Authors:  Christina M Maher; Jeffrey D Thomas; Derick A Haas; Charles G Longen; Halley M Oyer; Jane Y Tong; Felix J Kim
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

8.  Selective antagonism of opioid analgesia by a sigma system.

Authors:  C C Chien; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

9.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

10.  Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice.

Authors:  Elaine Tan; Xi-Qin Ding; Anisse Saadi; Neeraj Agarwal; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-03       Impact factor: 4.799

View more
  2 in total

1.  Enantioselective Addition of α-Nitroesters to Alkynes.

Authors:  Ryan T Davison; Patrick D Parker; Xintong Hou; Crystal P Chung; Sara A Augustine; Vy M Dong
Journal:  Angew Chem Int Ed Engl       Date:  2021-01-07       Impact factor: 15.336

2.  Comparison of Sigma 1 Receptor Ligands SA4503 and PRE084 to (+)-Pentazocine in the rd10 Mouse Model of RP.

Authors:  Jing Wang; Haiyan Xiao; Shannon R Barwick; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.